Background The degree to which abnormal glucose tolerance contributes to the development of coronary artery disease (CAD) has not been clarified in Japanese. The relationship between abnormal glucose tolerance and severity of coronary artery stenosis, as well as the contributions of hypertension, diabetes and other risk factors for CAD to recurrence of the disease, were investigated in the present study.
here is concern about the reported dramatic increases in recent years in the incidences of diabetes mellitus (DM) and impaired glucose tolerance (IGT) in Japanese, [1] [2] [3] and it is known that coronary artery disease (CAD) is severe in diabetic patients and they have a poor prognosis. [4] [5] [6] [7] There have also been reports on the contribution of abnormal glucose tolerance, including impaired fasting glucose (IFG) and IGT, to the development of CAD, [8] [9] [10] [11] but there have been only a few reports on the impact of glucose intolerance on severity of coronary artery stenosis determined by coronary angiography. 12, 13 Therefore, using patients admitted to Sapporo Medical University Hospital as subjects, we investigated the relationship between abnormal glucose tolerance and severity of coronary artery stenosis in a cross-sectional study, and we also investigated the contributions of insulin resistance (IR) and various risk factors for CAD, including hypertension (HT), DM, IGT, hyperlipidemia and obesity, to recurrence of ischemic episodes in a longitudinal study.
Methods

Study Population Relationship Between Abnormal Glucose Tolerance and Severity of Coronary Artery Stenosis (Cross-Sectional
Study) The subjects in the cross-sectional study were 474 consecutive patients (mean age: 63.8±11.3 years) who were admitted to Sapporo Medical University Hospital for investigation of chest pain and suspected CAD during the period from April 1, 1997 to March 31, 2004 and who were subsequently diagnosed as having CAD, based on findings from coronary angiography, nuclear medical examinations, and exercise and 12-lead electrocardiogram. Patients who had complications such as heart valve disease, pulmonary thromboembolism, aortic dissection, myocarditis, and pericarditis were excluded from the subjects. Of the 474 patients, 224 had acute coronary syndrome, including acute myocardial infarction and unstable angina, 148 had effort angina pectoris, 64 had silent myocardial ischemia, and 38 had vasospastic angina pectoris.
Relationships Between Risk Factors and Recurrence of Ischemic Episodes (Longitudinal Study)
Of the subjects who had been diagnosed as having CAD during their first admission and who had been discharged after successful revascularization and chest pain control had been achieved by percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and drug therapy, the recurrence group was defined as those who had chest pain be-cause of ischemia during their second admission and for whom results of exercise tolerance tests, nuclear medical examinations and imaging examinations carried out regularly on an out-patient basis confirmed ischemia.
In order to compare the data for patients with recurrence of myocardial ischemia and patients without recurrence, we carried out a longitudinal study using 341 subjects (mean age: 63.2±12.0 years) selected from those in the crosssectional study for whom follow-up was possible. There was no difference between items evaluated in the subjects during admission in the cross-sectional study and the follow-up subjects.
Study Protocol
Cross-Sectional Study Coronary angiography was performed on 380 of the 474 subjects in the cross-sectional study and based on the results stenosis was scored according to the American Heart Association functional classification: 14 5 points for 99-100% stenosis, 4 for 90%, 3 for 75%, 2 for 50%, 1 for 25% and 0 for 0%. The maximum coronary stenosis point in each case in the left anterior descending artery, left circumflex artery, or right coronary artery was defined as the coronary index, 14 and the stenosis score 14 was calculated as the sum of the stenosis points of each branch.
The following items were measured in the early morning after overnight fasting during admission: body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), hemoglobin (Hb) A1c, total cholesterol (TC), triglyceride (TG), and high-density lipoprotein-cholesterol (HDL-C). Low-density lipoprotein-cholesterol (LDL-C) was calculated by Friedewald's formula. 15 Subjects who showed symptoms of DM or who had a casual plasma glucose (PG) level ≥200 mg/dl, FPG ≥126 mg/dl or 2h-PG during a 75-g oral glucose tolerance test (OGTT) ≥200 mg/dl were diagnosed as having DM according to the ADA criteria. 16 Subjects who had 2h-PG ≥140 mg/dl and 2h-PG <200 mg/dl were diagnosed as having IGT, and those who had FPG ≥110 mg/dl and FPG <126 mg/dl were diagnosed as having IFG.
Subjects with a family history of CAD were defined as those with any family member within 2 generations having CAD. Subjects with a smoking habit were defined as current smokers who smoked 1 or more cigarettes per day. Subjects with a drinking habit were defined as all of those who drank other than those who drank only on special occasions.
Data obtained at the time of discharge were used for analysis of the relationship between glucose tolerance and severity of coronary artery stenosis.
Longitudinal Study The endpoint of the longitudinal study was recurrence of ischemic episodes during the observation period, which was 2.4 years.
Items evaluated during admission in this series of study were the same as those in the cross-sectional study. Relationships between recurrence of ischemic episodes and coronary risk factors, including HT, abnormal glucose tolerance, hyperlipidemia and obesity, were analysed. Because the number of follow-up subjects with IGT (n=25) was small, we divided the follow-up subjects into normal glucose tolerance (NGT) and IFG + IGT + DM groups for comparison of the rates of recurrence.
Eighty-five patients underwent 75-g OGTT, and those who had an insulin concentration 2 h after glucose loading (120 min IRI) ≥64 mU/L were defined as the IR group. 17 We compared the rates of ischemic episodes recurrence in the IR group and non-insulin resistance (NR) group to determine whether IR is associated with recurrence of ischemic episodes.
Statistical Analysis
Data are expressed as means ± standard deviation. Differences between mean values in 2 groups were examined by the unpaired t-test. One-way ANOVA was used to examine differences between mean values in the 3 groups (NGT, IFG + IGT, and DM), and multiple logistic regression analysis was used to examine relations between ischemic episode recurrence and other risk factors. A p-value of less than 0.05 in these analyses was considered significant. All statistical analyses were performed using SPSS version 12.0J (Chicago, IL, USA). Table 1 shows a comparison of data in the NGT, IFG + IGT and DM groups. The percentage of subjects with a family history of CAD was significantly higher in the IFG + IGT group than in the other 2 groups. 
Results
Relationship Between Abnormal Glucose Tolerance and Severity of Coronary Artery Stenosis (Cross-Sectional Study)
Relationships Between Risk Factors and Recurrence of Ischemic Episodes (Longitudinal Study)
Ischemic episodes recurred in 61 of the 341 subjects during the observation period. Table 3 shows a comparison of risk factors in subjects with recurrence of ischemia and those without the recurrence. SBP and BMI were significantly higher in the recurrence group than in the non-recurrence group. Table 4 shows the results of multiple logistic regression analysis using ischemic episode recurrence as an independent variable. When adjustments were made for age, gender, HbA1c, TC, BMI, smoking history, family history and stenosis score, SBP became a significant variable for recurrence, and the relative risk of recurrent ischemia was 1.7-fold higher with a rise in SBP of 10 mmHg. The rates of ischemic episode recurrence for the NGT and IFG + IGT + DM groups are shown in Fig 1. The rate of recurrence was higher in the IFG + IGT + DM group (23.4%) than in the NGT group (11.2%) (p=0.004). When we defined IR according to the plasma insulin level 2 h after glucose loading as stated before, the rate of recurrence of ischemia in the IR group was higher than that in the NR group (Fig 2) 
Discussion
Relationship Between Abnormal Glucose Tolerance and Severity of Coronary Artery Stenosis (Cross-Sectional Study)
The subjects with DM in this study also showed stenosis in many coronary artery branches and severe stenosis. Diabetes is often complicated with CAD, and it has been shown that diabetes also has a significant untoward effect on the prognosis and severity of CAD. Our findings agree with the results of a study by Dortimer et al showing that many patients with diabetes had stenosis in 3 branches of the coronary artery, 18 and the results of a study by Kip et al showing extensive diffuse coronary arteriosclerosis in diabetics with CAD. 19 The results of the present study indicate that not only subjects with diabetes but also those with abnormal glucose tolerance have more severe stenosis and stenosis in more vessels than subjects with NGT. However, the association of abnormal glucose tolerance with severity of CAD is not fully characterized. 12, 13 The study by Kataoka et al showed a significant correlation between IGT and severity of CAD, 12 and our results agree with their finding. However, the study by Horimoto et al suggested that there was no significant difference between the severity of angiographic coronary atherosclerosis in subjects with NGT and IGT. 13 This discrepancy may be related to the small numbers of subjects, and differences in the characteristics of the subjects entered in the study protocols. Nevertheless, further investigation of this issue is needed.
It has been shown that individuals with abnormal glucose tolerance have IR in addition to a high PG level. Currently, whether hyperglycemia in IGT patients or IR are responsible for the IGT-CAD association has been a subject of investigation. Recently, Satoh et al 20 and Takezako et al 21 have reported that IR rather than hyperglycemia is associated with the severity of CAD. In our study, we examined the relationships between number of diseased vessels, 2h-PG and 120 min IRI using subjects other than those with DM. We found that subjects with multiple vessel disease had higher values for both 2h-PG (patients with multiple vessel disease vs patients with 1 diseased vessel or less: 139.3± 27.1 mg/dl vs 116.5±21.2 mg/dl; p<0.001) and 120 min IRI (92.3±58.7 mU/L vs 67.6±39.1 mU/L; p=0.05) compared with subjects with 1 diseased vessel or less. This suggests that both postprandial hyperglycemia and hyperinsulinemia are involved in the development of CAD in patients with IGT.
IR results in compensatory hyperinsulinemia, which may give rise to an accumulation of risk factors for CAD, provoking a direct mechanism for the progression of arteriosclerosis. It has, in fact, been reported that subjects with IR have a high incidence of cardiovascular disease 22 and show progression of CAD, 23, 24 and our results also suggest that IR is involved in the progression of CAD. We previously reported that CAD in IR is characterized by stenosis of multiple coronary artery branches and peripheral lesions. 24 Not only the accumulation of risk factors for CAD but also a reduction in blood flow in the coronary artery occur in a state of IR, 25 and it is possible that these factors, acting either alone or synergistically, cause progression of CAD.
Relationships Between Risk Factors and Recurrence of Ischemic Episodes (Longitudinal Study)
There was no difference between FPG or lipid levels in the recurrence group and non-recurrence group, but SBP and BMI were significantly higher in the recurrence group. We found in the present study that SBP contributed significantly to recurrence of ischemic episodes, even when adjustments were made for age, gender, HbA1c, TC, BMI, smoking history, family history and stenosis score, and that the relative risk of recurrence was 1.7-fold higher with a rise in SBP of 10 mmHg. Although there have been only a few studies on the relationship between blood pressure and recurrence of ischemic episodes, Xiao-Fei Zhang et al 26 found that higher SBP increases the mortality from cardiovascular disease in Chinese subjects, and our findings agree with their report. In the present study, there was no significant difference between the percentages of subjects receiving hypotensive drugs in the non-recurrence group (90.0%) and recurrence group (93.2%). There was also no significant difference between the 2 groups in the percentages of subjects taking an angiotensin-converting enzyme inhibitor, an angiotensin-receptor blocker, a Ca 2+ antagonist or a diuretic drug, suggesting that high blood pressure has a direct effect on recurrence of ischemic episodes.
It has been reported that obesity is involved in the onset of CAD 27, 28 and in the present study BMI was found to be significantly higher in the recurrence group, which is consistent with the recently proposed concept of metabolic syndrome in which abdominal obesity is an important risk factor for cardiovascular disease.
The rate of recurrence of ischemic episodes was higher in subjects with IFG + IGT + DM than in subjects with NGT. However, no significant difference was found between the levels of FPG or HbA1c or the frequencies of use of hypoglycemic drugs or insulin in the recurrence and non-recurrence groups. On the other hand, analysis of the effect of IR, assessed by the insulin concentration 2 h after glucose loading, 17 showed that the rate of recurrence was significantly higher in the IR group than in the NR group. These results suggest that IR rather than hyperglycemia increases the risk of recurrence of ischemic episodes, which agrees with an earlier study 29 showing association of IR with coro- nary restenosis after PCI. Lipid profile did not differ between the recurrence group and the non-recurrence group except for TC, which was significantly lower in the recurrence group, presumably because of the strict control of TC level in the subjects during their hospitalization. The proportion of subjects taking cholesterol-lowering drugs was approximately 50% in both groups.
Study Limitations
This study has 3 limitations. First, subjects were hospitalized at least once, and in many of the cases, CAD was severe. Second, the number of subjects was relatively small. Further investigation using a larger number of subjects is necessary to confirm the present observation. The third limitation concerns recurrence. In this study, the recurrence group of subjects was defined as those who had been diagnosed as having CAD during their first admission and who had been discharged after receiving PCI, CABG and drug therapy and then had chest pain because of ischemia, which was confirmed by results of exercise tolerance tests, nuclear medical examinations and imaging examinations carried out regularly on an outpatient basis, during their second admission. The methods used for diagnosis and the treatment methods differed among the subjects, and the criteria for diagnosis of recurrence were not uniform. However, data for all of the subjects included in the recurrence group were used for analysis because exclusion of subjects not strictly meeting the criteria would have resulted in a very small number of subjects. It is also possible that the mechanisms of restenosis and new stenosis of the coronary artery are different, and the risk factors for new stenosis might not always be involved in restenosis. However, in this study, there were few cases of confirmed new stenosis, and some of the cases of confirmed new stenosis also included restenosis. It has also been reported that the rate of restenosis is high in cases of CAD complicated with DM. In this study, we therefore did not differentiate restenosis and new stenosis in our analysis of the effects of risk factors on stenosis.
In conclusion, our study revealed that CAD progresses at the stage of abnormal glucose tolerance and that the rate of ischemic episode recurrence increases in individuals with abnormal glucose tolerance, DM and HT. Therefore, it is important to manage and control glucose tolerance, IR and blood pressure for prevention of CAD.
